Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. Patrick L Raber, Paul Thevenot, +9 authors, Rosa Sierra, Dorota Wyczechowska, Daniel Halle, Maria E Ramirez, Augusto C Ochoa, Matthew Fletcher, Cruz Velasco, Anna Wilk, Krzysztof Reiss, Paulo C Rodriguez. less Int J Cancer, 2013 Nov 22; 134(12). PMID: 24259296 Free PMC article.
|
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma. Paolo Antonio Ascierto, Pier Francesco Ferrucci, +16 authors, Rosalie Fisher, Michele Del Vecchio, Victoria Atkinson, Henrik Schmidt, Jacob Schachter, Paola Queirolo, Georgina V Long, Anna Maria Di Giacomo, Inge Marie Svane, Michal Lotem, Gil Bar-Sela, Felix Couture, Bijoyesh Mookerjee, Razi Ghori, Nageatte Ibrahim, Blanca Homet Moreno, Antoni Ribas. less Nat Med, 2019 Jun 07; 25(6). PMID: 31171878 Highly Cited.
|
Moderate physical exercise improves lymphocyte function in melanoma-bearing mice on a high-fat diet. Cesar Miguel Momesso Dos Santos, Vinicius Leonardo Sousa Diniz, +13 authors, André Luis Lacerda Bachi, Laiane Cristina Dos Santos de Oliveira, Tamara Ghazal, Maria Elizabeth Pereira Passos, Heloisa Helena de Oliveira, Gilson Murata, Laureane Nunes Masi, Amanda Roque Martins, Adriana Cristina Levada-Pires, Rui Curi, Sandro Massao Hirabara, Donald F Sellitti, Tania Cristina Pithon-Curi, Renata Gorjão. less Nutr Metab (Lond), 2019 Sep 19; 16. PMID: 31528182 Free PMC article.
|
Melanoma: a prototype of cancer-testis antigen-expressing malignancies. Sepideh Faramarzi, Soudeh Ghafouri-Fard. Immunotherapy, 2017 Oct 17; 9(13). PMID: 29032737 Review.
|
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma. Ricardo E Vilain, Alexander M Menzies, +15 authors, James S Wilmott, Hojabr Kakavand, Jason Madore, Alexander Guminski, Elizabeth Liniker, Benjamin Y Kong, Adam J Cooper, Julie R Howle, Robyn P M Saw, Valerie Jakrot, Serigne Lo, John F Thompson, Matteo S Carlino, Richard F Kefford, Georgina V Long, Richard A Scolyer. less Clin Cancer Res, 2017 May 18; 23(17). PMID: 28512174 Highly Cited.
|
Nanoenabled Modulation of Acidic Tumor Microenvironment Reverses Anergy of Infiltrating T Cells and Potentiates Anti-PD-1 Therapy. Yu-Xue Zhang, Yang-Yang Zhao, +5 authors, Jizhou Shen, Xun Sun, Yi Liu, Hang Liu, Yucai Wang, Jun Wang. less Nano Lett, 2019 Apr 04; 19(5). PMID: 30943039
|
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Robert D Schreiber, Lloyd J Old, Mark J Smyth. Science, 2011 Mar 26; 331(6024). PMID: 21436444 Highly Cited. Review.
|
Anti-PD1 in the wonder-gut-land. Marie Vetizou, Giorgio Trinchieri. Cell Res, 2018 Jan 18; 28(3). PMID: 29336431 Free PMC article.
|
The Immunology of Melanoma. Jennifer S Ko. Clin Lab Med, 2017 Aug 15; 37(3). PMID: 28802495 Review.
|
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. Robert H I Andtbacka, Howard L Kaufman, +26 authors, Frances Collichio, Thomas Amatruda, Neil Senzer, Jason Chesney, Keith A Delman, Lynn E Spitler, Igor Puzanov, Sanjiv S Agarwala, Mohammed Milhem, Lee Cranmer, Brendan Curti, Karl Lewis, Merrick Ross, Troy Guthrie, Gerald P Linette, Gregory A Daniels, Kevin Harrington, Mark R Middleton, Wilson H Miller, Jonathan S Zager, Yining Ye, Bin Yao, Ai Li, Susan Doleman, Ari VanderWalde, Jennifer Gansert, Robert S Coffin. less J Clin Oncol, 2015 May 28; 33(25). PMID: 26014293 Highly Cited.
|
Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients. Kimberly R Jordan, Rodabe N Amaria, +6 authors, Oscar Ramirez, Eryn B Callihan, Dexiang Gao, Michelle Borakove, Elizabeth Manthey, Virginia F Borges, Martin D McCarter. less Cancer Immunol Immunother, 2013 Sep 28; 62(11). PMID: 24072401 Free PMC article.
|
Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes. Woo Jin Lee, Ye Jin Lee, +5 authors, Myoung Eun Choi, Kyung A Yun, Chong Hyun Won, Mi Woo Lee, Jee Ho Choi, Sung Eun Chang. less J Am Acad Dermatol, 2019 Mar 19; 81(1). PMID: 30880064
|
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Nadeem Riaz, Jonathan J Havel, +22 authors, Vladimir Makarov, Alexis Desrichard, Walter J Urba, Jennifer S Sims, F Stephen Hodi, Salvador Martín-Algarra, Rajarsi Mandal, William H Sharfman, Shailender Bhatia, Wen-Jen Hwu, Thomas F Gajewski, Craig L Slingluff, Diego Chowell, Sviatoslav M Kendall, Han Chang, Rachna Shah, Fengshen Kuo, Luc G T Morris, John-William Sidhom, Jonathan P Schneck, Christine E Horak, Nils Weinhold, Timothy A Chan. less Cell, 2017 Oct 17; 171(4). PMID: 29033130 Free PMC article. Highly Cited.
|
Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies. Yumi Kambayashi, Taku Fujimura, Takanori Hidaka, Setsuya Aiba. Front Med (Lausanne), 2019 Aug 17; 6. PMID: 31417907 Free PMC article. Review.
|
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. Mark Ayers, Jared Lunceford, +12 authors, Michael Nebozhyn, Erin Murphy, Andrey Loboda, David R Kaufman, Andrew Albright, Jonathan D Cheng, S Peter Kang, Veena Shankaran, Sarina A Piha-Paul, Jennifer Yearley, Tanguy Y Seiwert, Antoni Ribas, Terrill K McClanahan. less J Clin Invest, 2017 Jun 27; 127(8). PMID: 28650338 Free PMC article. Highly Cited.
|
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. Paolo Serafini, Kristen Meckel, +6 authors, Michael Kelso, Kimberly Noonan, Joseph Califano, Wayne Koch, Luigi Dolcetti, Vincenzo Bronte, Ivan Borrello. less J Exp Med, 2006 Nov 15; 203(12). PMID: 17101732 Free PMC article. Highly Cited.
|
No association between prediagnosis exercise and survival in patients with high-risk primary melanoma: A population-based study. Emily Schwitzer, Irene Orlow, +6 authors, Emily C Zabor, Colin B Begg, Marianne Berwick, Nancy E Thomas, Peter A Kanetsky, Lee W Jones, GEM Study Group. less Pigment Cell Melanoma Res, 2017 Apr 12; 30(4). PMID: 28397350 Free PMC article.
|
Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review. Rodolfo Chicas-Sett, Ignacio Morales-Orue, Delvys Rodriguez-Abreu, Pedro Lara-Jimenez. Clin Transl Radiat Oncol, 2018 Mar 30; 9. PMID: 29594244 Free PMC article. Review.
|
The Role of Immune Checkpoint Blockade in Uveal Melanoma. Anja Wessely, Theresa Steeb, +5 authors, Michael Erdmann, Lucie Heinzerling, Julio Vera, Max Schlaak, Carola Berking, Markus Vincent Heppt. less Int J Mol Sci, 2020 Feb 06; 21(3). PMID: 32013269 Free PMC article. Review.
|
Cancer immunoediting: from immunosurveillance to tumor escape. Gavin P Dunn, Allen T Bruce, +2 authors, Hiroaki Ikeda, Lloyd J Old, Robert D Schreiber. less Nat Immunol, 2002 Oct 31; 3(11). PMID: 12407406 Highly Cited. Review.
|
Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients. Marine Cordonnier, Charlée Nardin, +6 authors, Gaëtan Chanteloup, Valentin Derangere, Marie-Paule Algros, Laurent Arnould, Carmen Garrido, François Aubin, Jessica Gobbo. less J Extracell Vesicles, 2020 Feb 01; 9(1). PMID: 32002173 Free PMC article.
|
Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases. Ricarda Rauschenberg, Johannes Bruns, +24 authors, Julia Brütting, Dirk Daubner, Fabian Lohaus, Lisa Zimmer, Andrea Forschner, Daniel Zips, Jessica C Hassel, Carola Berking, Katharina C Kaehler, Jochen Utikal, Ralf Gutzmer, Patrik Terheyden, Frank Meiss, David Rafei-Shamsabadi, Felix Kiecker, Dirk Debus, Evelyn Dabrowski, Andreas Arnold, Marlene Garzarolli, Marvin Kuske, Stefan Beissert, Steffen Löck, Jennifer Linn, Esther G C Troost, Friedegund Meier. less Eur J Cancer, 2019 Feb 12; 110. PMID: 30739835
|
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial. Georgina V Long, Victoria Atkinson, +21 authors, Jonathan S Cebon, Michael B Jameson, Bernie M Fitzharris, Catriona M McNeil, Andrew G Hill, Antoni Ribas, Michael B Atkins, John A Thompson, Wen-Jen Hwu, F Stephen Hodi, Alexander M Menzies, Alexander D Guminski, Richard Kefford, Benjamin Y Kong, Babak Tamjid, Archana Srivastava, Anna J Lomax, Mohammed Islam, Xinxin Shu, Scot Ebbinghaus, Nageatte Ibrahim, Matteo S Carlino. less Lancet Oncol, 2017 Jul 22; 18(9). PMID: 28729151 Highly Cited.
|
Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET-CT. Antonia Dimitrakopoulou-Strauss. Cancer Immunol Immunother, 2018 Aug 21; 68(5). PMID: 30123922 Review.
|
CD28, CTLA-4 and their ligands: who does what and to whom? D M Sansom. Immunology, 2000 Sep 30; 101(2). PMID: 11012769 Free PMC article. Review.
|
An immunogenic personal neoantigen vaccine for patients with melanoma. Patrick A Ott, Zhuting Hu, +37 authors, Derin B Keskin, Sachet A Shukla, Jing Sun, David J Bozym, Wandi Zhang, Adrienne Luoma, Anita Giobbie-Hurder, Lauren Peter, Christina Chen, Oriol Olive, Todd A Carter, Shuqiang Li, David J Lieb, Thomas Eisenhaure, Evisa Gjini, Jonathan Stevens, William J Lane, Indu Javeri, Kaliappanadar Nellaiappan, Andres M Salazar, Heather Daley, Michael Seaman, Elizabeth I Buchbinder, Charles H Yoon, Maegan Harden, Niall Lennon, Stacey Gabriel, Scott J Rodig, Dan H Barouch, Jon C Aster, Gad Getz, Kai Wucherpfennig, Donna Neuberg, Jerome Ritz, Eric S Lander, Edward F Fritsch, Nir Hacohen, Catherine J Wu. less Nature, 2017 Jul 06; 547(7662). PMID: 28678778 Free PMC article. Highly Cited.
|
Recent success and limitations of immune checkpoint inhibitors for cancer: a lesson from melanoma. Margaret Ottaviano, Sabino De Placido, Paolo Antonio Ascierto. Virchows Arch, 2019 Feb 13; 474(4). PMID: 30747264 Review.
|
On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment. Grazia R Tundo, Diego Sbardella, +2 authors, Pedro M Lacal, Grazia Graziani, Stefano Marini. less Chemotherapy, 2019 Aug 07; 64(2). PMID: 31387102 Review.
|
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade. Livnat Jerby-Arnon, Parin Shah, +49 authors, Michael S Cuoco, Christopher Rodman, Mei-Ju Su, Johannes C Melms, Rachel Leeson, Abhay Kanodia, Shaolin Mei, Jia-Ren Lin, Shu Wang, Bokang Rabasha, David Liu, Gao Zhang, Claire Margolais, Orr Ashenberg, Patrick A Ott, Elizabeth I Buchbinder, Rizwan Haq, F Stephen Hodi, Genevieve M Boland, Ryan J Sullivan, Dennie T Frederick, Benchun Miao, Tabea Moll, Keith T Flaherty, Meenhard Herlyn, Russell W Jenkins, Rohit Thummalapalli, Monika S Kowalczyk, Israel Cañadas, Bastian Schilling, Adam N R Cartwright, Adrienne M Luoma, Shruti Malu, Patrick Hwu, Chantale Bernatchez, Marie-Andrée Forget, David A Barbie, Alex K Shalek, Itay Tirosh, Peter K Sorger, Kai Wucherpfennig, Eliezer M Van Allen, Dirk Schadendorf, Bruce E Johnson, Asaf Rotem, Orit Rozenblatt-Rosen, Levi A Garraway, Charles H Yoon, Benjamin Izar, Aviv Regev. less Cell, 2018 Nov 06; 175(4). PMID: 30388455 Free PMC article. Highly Cited.
|
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Janis M Taube, Robert A Anders, +8 authors, Geoffrey D Young, Haiying Xu, Rajni Sharma, Tracee L McMiller, Shuming Chen, Alison P Klein, Drew M Pardoll, Suzanne L Topalian, Lieping Chen. less Sci Transl Med, 2012 Mar 31; 4(127). PMID: 22461641 Free PMC article. Highly Cited.
|
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma. Antoni Ribas, Donald Lawrence, +14 authors, Victoria Atkinson, Sachin Agarwal, Wilson H Miller, Matteo S Carlino, Rosalie Fisher, Georgina V Long, F Stephen Hodi, Jennifer Tsoi, Catherine S Grasso, Bijoyesh Mookerjee, Qing Zhao, Razi Ghori, Blanca Homet Moreno, Nageatte Ibrahim, Omid Hamid. less Nat Med, 2019 Jun 07; 25(6). PMID: 31171879 Free PMC article. Highly Cited.
|
Targeted agents and immunotherapies: optimizing outcomes in melanoma. Jason J Luke, Keith T Flaherty, Antoni Ribas, Georgina V Long. Nat Rev Clin Oncol, 2017 Apr 05; 14(8). PMID: 28374786 Highly Cited. Review.
|
Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model. Alexandra Sevko, Tillmann Michels, +6 authors, Melissa Vrohlings, Ludmila Umansky, Philipp Beckhove, Masashi Kato, Galina V Shurin, Michael R Shurin, Viktor Umansky. less J Immunol, 2013 Jan 30; 190(5). PMID: 23359505 Free PMC article.
|
Anti-PD-1 and Novel Combinations in the Treatment of Melanoma-An Update. Frank Friedrich Gellrich, Marc Schmitz, Stefan Beissert, Friedegund Meier. J Clin Med, 2020 Jan 18; 9(1). PMID: 31947592 Free PMC article. Review.
|
Metformin: Focus on Melanoma. Emilie Jaune, Stéphane Rocchi. Front Endocrinol (Lausanne), 2018 Sep 07; 9. PMID: 30186236 Free PMC article. Review.
|
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy. Tuba N Gide, Camelia Quek, +22 authors, Alexander M Menzies, Annie T Tasker, Ping Shang, Jeff Holst, Jason Madore, Su Yin Lim, Rebecca Velickovic, Matthew Wongchenko, Yibing Yan, Serigne Lo, Matteo S Carlino, Alexander Guminski, Robyn P M Saw, Angel Pang, Helen M McGuire, Umaimainthan Palendira, John F Thompson, Helen Rizos, Ines Pires da Silva, Marcel Batten, Richard A Scolyer, Georgina V Long, James S Wilmott. less Cancer Cell, 2019 Feb 13; 35(2). PMID: 30753825 Highly Cited.
|
Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy. Hui-Ming Chen, Ge Ma, +13 authors, Neil Gildener-Leapman, Samuel Eisenstein, Brian A Coakley, Junko Ozao, John Mandeli, Celia Divino, Myron Schwartz, Max Sung, Robert Ferris, Johnny Kao, Lu-Hai Wang, Ping-Ying Pan, Eric C Ko, Shu-Hsia Chen. less Clin Cancer Res, 2015 Apr 30; 21(18). PMID: 25922428 Free PMC article.
|
Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy. Wei Xie, Wei-Wei Deng, +16 authors, Minghui Zan, Lang Rao, Guang-Tao Yu, Dao-Ming Zhu, Wen-Tao Wu, Bei Chen, Li-Wei Ji, Liben Chen, Kan Liu, Shi-Shang Guo, Hui-Ming Huang, Wen-Feng Zhang, Xingzhong Zhao, Yufeng Yuan, Wenfei Dong, Zhi-Jun Sun, Wei Liu. less ACS Nano, 2019 Feb 26; 13(3). PMID: 30803232
|
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial. Georgina V Long, Daniil Stroyakovskiy, +31 authors, Helen Gogas, Evgeny Levchenko, Filippo de Braud, James Larkin, Claus Garbe, Thomas Jouary, Axel Hauschild, Jean-Jacques Grob, Vanna Chiarion-Sileni, Celeste Lebbe, Mario Mandalà, Michael Millward, Ana Arance, Igor Bondarenko, John B A G Haanen, Johan Hansson, Jochen Utikal, Virginia Ferraresi, Nadezhda Kovalenko, Peter Mohr, Volodymr Probachai, Dirk Schadendorf, Paul Nathan, Caroline Robert, Antoni Ribas, Douglas J DeMarini, Jhangir G Irani, Suzanne Swann, Jeffrey J Legos, Fan Jin, Bijoyesh Mookerjee, Keith Flaherty. less Lancet, 2015 Jun 04; 386(9992). PMID: 26037941 Highly Cited.
|
Myeloid-derived suppressor cells as regulators of the immune system. Dmitry I Gabrilovich, Srinivas Nagaraj. Nat Rev Immunol, 2009 Feb 07; 9(3). PMID: 19197294 Free PMC article. Highly Cited. Review.
|
Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Christiane Meyer, Alexandra Sevko, +8 authors, Marcel Ramacher, Alexandr V Bazhin, Christine S Falk, Wolfram Osen, Ivan Borrello, Masashi Kato, Dirk Schadendorf, Michal Baniyash, Viktor Umansky. less Proc Natl Acad Sci U S A, 2011 Oct 05; 108(41). PMID: 21969559 Free PMC article. Highly Cited.
|
Targeting antigen-presenting cells by anti-PD-1 nanoparticles augments antitumor immunity. Farideh Ordikhani, Mayuko Uehara, +12 authors, Vivek Kasinath, Li Dai, Siawosh K Eskandari, Baharak Bahmani, Merve Yonar, Jamil R Azzi, Yousef Haik, Peter T Sage, George F Murphy, Nasim Annabi, Tobias Schatton, Indira Guleria, Reza Abdi. less JCI Insight, 2018 Oct 20; 3(20). PMID: 30333312 Free PMC article.
|
Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab. Jeffrey Weber, Geoffrey Gibney, +11 authors, Ragini Kudchadkar, Bin Yu, Pingyan Cheng, Alberto J Martinez, Jodie Kroeger, Allison Richards, Lori McCormick, Valerie Moberg, Heather Cronin, Xiuhua Zhao, Michael Schell, Yian Ann Chen. less Cancer Immunol Res, 2016 Feb 14; 4(4). PMID: 26873574 Free PMC article. Highly Cited.
|
TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients. Joe-Marc Chauvin, Ornella Pagliano, +8 authors, Julien Fourcade, Zhaojun Sun, Hong Wang, Cindy Sander, John M Kirkwood, Tseng-hui Timothy Chen, Mark Maurer, Alan J Korman, Hassane M Zarour. less J Clin Invest, 2015 Apr 14; 125(5). PMID: 25866972 Free PMC article. Highly Cited.
|
18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma. Kimiteru Ito, Rebecca Teng, +7 authors, Heiko Schöder, John L Humm, Ai Ni, Laure Michaud, Reiko Nakajima, Rikiya Yamashita, Jedd D Wolchok, Wolfgang A Weber. less J Nucl Med, 2018 Nov 11; 60(3). PMID: 30413661 Free PMC article.
|
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma. Muhammad Zubair Afzal, Rima R Mercado, Keisuke Shirai. J Immunother Cancer, 2018 Jul 04; 6(1). PMID: 29966520 Free PMC article.
|
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma. Willy Hugo, Jesse M Zaretsky, +15 authors, Lu Sun, Chunying Song, Blanca Homet Moreno, Siwen Hu-Lieskovan, Beata Berent-Maoz, Jia Pang, Bartosz Chmielowski, Grace Cherry, Elizabeth Seja, Shirley Lomeli, Xiangju Kong, Mark C Kelley, Jeffrey A Sosman, Douglas B Johnson, Antoni Ribas, Roger S Lo. less Cell, 2016 Mar 22; 165(1). PMID: 26997480 Free PMC article. Highly Cited.
|
TIGIT: A Key Inhibitor of the Cancer Immunity Cycle. Nicholas A Manieri, Eugene Y Chiang, Jane L Grogan. Trends Immunol, 2016 Oct 30; 38(1). PMID: 27793572 Review.
|
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Xin Yu, Kristin Harden, +9 authors, Lino C Gonzalez, Michelle Francesco, Eugene Chiang, Bryan Irving, Irene Tom, Sinisa Ivelja, Canio J Refino, Hilary Clark, Dan Eaton, Jane L Grogan. less Nat Immunol, 2008 Nov 18; 10(1). PMID: 19011627 Highly Cited.
|
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Zachary R Chalmers, Caitlin F Connelly, +21 authors, David Fabrizio, Laurie Gay, Siraj M Ali, Riley Ennis, Alexa Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki, Franklin Huang, Yuting He, James Sun, Uri Tabori, Mark Kennedy, Daniel S Lieber, Steven Roels, Jared White, Geoffrey A Otto, Jeffrey S Ross, Levi Garraway, Vincent A Miller, Phillip J Stephens, Garrett M Frampton. less Genome Med, 2017 Apr 20; 9(1). PMID: 28420421 Free PMC article. Highly Cited.
|
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways. Yunlong Zhao, Calvin K Lee, +8 authors, Chia-Hao Lin, Rodrigo B Gassen, Xiaozheng Xu, Zhe Huang, Changchun Xiao, Cristina Bonorino, Li-Fan Lu, Jack D Bui, Enfu Hui. less Immunity, 2019 Nov 24; 51(6). PMID: 31757674 Free PMC article.
|
Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Gulsun Erdag, Jochen T Schaefer, +5 authors, Mark E Smolkin, Donna H Deacon, Sofia M Shea, Lynn T Dengel, James W Patterson, Craig L Slingluff. less Cancer Res, 2012 Jan 24; 72(5). PMID: 22266112 Free PMC article. Highly Cited.
|
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma. Jeffrey Weber, Mario Mandala, +32 authors, Michele Del Vecchio, Helen J Gogas, Ana M Arance, C Lance Cowey, Stéphane Dalle, Michael Schenker, Vanna Chiarion-Sileni, Ivan Marquez-Rodas, Jean-Jacques Grob, Marcus O Butler, Mark R Middleton, Michele Maio, Victoria Atkinson, Paola Queirolo, Rene Gonzalez, Ragini R Kudchadkar, Michael Smylie, Nicolas Meyer, Laurent Mortier, Michael B Atkins, Georgina V Long, Shailender Bhatia, Celeste Lebbé, Piotr Rutkowski, Kenji Yokota, Naoya Yamazaki, Tae M Kim, Veerle de Pril, Javier Sabater, Anila Qureshi, James Larkin, Paolo A Ascierto, CheckMate 238 Collaborators. less N Engl J Med, 2017 Sep 12; 377(19). PMID: 28891423 Highly Cited.
|
Gemcitabine nanoparticles promote antitumor immunity against melanoma. Yuan Zhang, Xin Bush, Bingfang Yan, Justin A Chen. Biomaterials, 2018 Nov 06; 189. PMID: 30388589 Free PMC article.
|
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade. Jun Zhou, Kathleen M Mahoney, +13 authors, Anita Giobbie-Hurder, Fengmin Zhao, Sandra Lee, Xiaoyun Liao, Scott Rodig, Jingjing Li, Xinqi Wu, Lisa H Butterfield, Matthias Piesche, Michael P Manos, Lauren M Eastman, Glenn Dranoff, Gordon J Freeman, F Stephen Hodi. less Cancer Immunol Res, 2017 May 20; 5(6). PMID: 28522460 Free PMC article. Highly Cited.
|
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Gang Chen, Alexander C Huang, +36 authors, Wei Zhang, Gao Zhang, Min Wu, Wei Xu, Zili Yu, Jiegang Yang, Beike Wang, Honghong Sun, Houfu Xia, Qiwen Man, Wenqun Zhong, Leonardo F Antelo, Bin Wu, Xuepeng Xiong, Xiaoming Liu, Lei Guan, Ting Li, Shujing Liu, Ruifeng Yang, Youtao Lu, Liyun Dong, Suzanne McGettigan, Rajasekharan Somasundaram, Ravi Radhakrishnan, Gordon Mills, Yiling Lu, Junhyong Kim, Youhai H Chen, Haidong Dong, Yifang Zhao, Giorgos C Karakousis, Tara C Mitchell, Lynn M Schuchter, Meenhard Herlyn, E John Wherry, Xiaowei Xu, Wei Guo. less Nature, 2018 Aug 10; 560(7718). PMID: 30089911 Free PMC article. Highly Cited.
|
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression. Viktor Fleming, Xiaoying Hu, +5 authors, Rebekka Weber, Vasyl Nagibin, Christopher Groth, Peter Altevogt, Jochen Utikal, Viktor Umansky. less Front Immunol, 2018 Mar 20; 9. PMID: 29552012 Free PMC article. Highly Cited. Review.
|
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs. Brian J Christmas, Christine I Rafie, +9 authors, Alexander C Hopkins, Blake A Scott, Hayley S Ma, Kayla A Cruz, Skylar Woolman, Todd D Armstrong, Roisin M Connolly, Nilo A Azad, Elizabeth M Jaffee, Evanthia T Roussos Torres. less Cancer Immunol Res, 2018 Oct 21; 6(12). PMID: 30341213 Free PMC article.
|
A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma. Susan M Hiniker, Sunil A Reddy, +6 authors, Holden T Maecker, Priyanka B Subrahmanyam, Yael Rosenberg-Hasson, Susan M Swetter, Saurabh Saha, Lei Shura, Susan J Knox. less Int J Radiat Oncol Biol Phys, 2016 Sep 30; 96(3). PMID: 27681753 Free PMC article. Highly Cited.
|
TIGIT: a novel immunotherapy target moving from bench to bedside. Benjamin L Solomon, Ignacio Garrido-Laguna. Cancer Immunol Immunother, 2018 Sep 21; 67(11). PMID: 30232519 Highly Cited. Review.
|
Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models. Li Shen, Michael Ciesielski, +6 authors, Swathi Ramakrishnan, Kiersten M Miles, Leigh Ellis, Paula Sotomayor, Protul Shrikant, Robert Fenstermaker, Roberto Pili. less PLoS One, 2012 Feb 04; 7(1). PMID: 22303460 Free PMC article.
|
Exercise Behaviors and Fatigue in Patients Receiving Immunotherapy for Advanced Melanoma: A Cross-Sectional Survey via Social Media. Amelia Hyatt, Allison Drosdowsky, +5 authors, Narelle Williams, Elizabeth Paton, Fiona Bennett, Hayley Andersen, Jared Mathai, Donna Milne. less Integr Cancer Ther, 2019 Aug 07; 18. PMID: 31382768 Free PMC article.
|
Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Outcome of Immune Checkpoint Inhibitors. Xianhe Xie, Junjin Liu, +7 authors, Haitao Yang, Huijuan Chen, Sijing Zhou, Heng Lin, Ziyuan Liao, Yin Ding, Liting Ling, Xuewen Wang. less Cancer Invest, 2019 Jul 16; 37(6). PMID: 31304800
|
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option. Maartje W Rohaan, Joost H van den Berg, Pia Kvistborg, John B A G Haanen. J Immunother Cancer, 2018 Oct 05; 6(1). PMID: 30285902 Free PMC article. Review.
|
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients. M F Sanmamed, J L Perez-Gracia, +17 authors, K A Schalper, J P Fusco, A Gonzalez, M E Rodriguez-Ruiz, C Oñate, G Perez, C Alfaro, S Martín-Algarra, M P Andueza, A Gurpide, M Morgado, J Wang, A Bacchiocchi, R Halaban, H Kluger, L Chen, M Sznol, I Melero. less Ann Oncol, 2017 Jun 09; 28(8). PMID: 28595336 Free PMC article. Highly Cited.
|
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. Muhammad Zaeem Noman, Giacomo Desantis, +5 authors, Bassam Janji, Meriem Hasmim, Saoussen Karray, Philippe Dessen, Vincenzo Bronte, Salem Chouaib. less J Exp Med, 2014 Apr 30; 211(5). PMID: 24778419 Free PMC article. Highly Cited.
|
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. O Michielin, A C J van Akkooi, +3 authors, P A Ascierto, R Dummer, U Keilholz, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. less Ann Oncol, 2019 Oct 01; 30(12). PMID: 31566661 Highly Cited.
|
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer. Cristina Iclozan, Scott Antonia, +2 authors, Alberto Chiappori, Dung-Tsa Chen, Dmitry Gabrilovich. less Cancer Immunol Immunother, 2013 Apr 17; 62(5). PMID: 23589106 Free PMC article. Highly Cited.
|
Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Jennifer S Ko, Arnold H Zea, +10 authors, Brian I Rini, Joanna L Ireland, Paul Elson, Peter Cohen, Ali Golshayan, Patricia A Rayman, Laura Wood, Jorge Garcia, Robert Dreicer, Ronald Bukowski, James H Finke. less Clin Cancer Res, 2009 Mar 12; 15(6). PMID: 19276286 Highly Cited.
|
Improved overall survival in melanoma with combined dabrafenib and trametinib. Caroline Robert, Boguslawa Karaszewska, +24 authors, Jacob Schachter, Piotr Rutkowski, Andrzej Mackiewicz, Daniil Stroiakovski, Michael Lichinitser, Reinhard Dummer, Florent Grange, Laurent Mortier, Vanna Chiarion-Sileni, Kamil Drucis, Ivana Krajsova, Axel Hauschild, Paul Lorigan, Pascal Wolter, Georgina V Long, Keith Flaherty, Paul Nathan, Antoni Ribas, Anne-Marie Martin, Peng Sun, Wendy Crist, Jeff Legos, Stephen D Rubin, Shonda M Little, Dirk Schadendorf. less N Engl J Med, 2014 Nov 18; 372(1). PMID: 25399551 Highly Cited.
|
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response? Zijun Y Xu-Monette, Mingzhi Zhang, Jianyong Li, Ken H Young. Front Immunol, 2017 Dec 20; 8. PMID: 29255458 Free PMC article. Highly Cited. Review.
|
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome. Hashem O Alsaab, Samaresh Sau, +4 authors, Rami Alzhrani, Katyayani Tatiparti, Ketki Bhise, Sushil K Kashaw, Arun K Iyer. less Front Pharmacol, 2017 Sep 08; 8. PMID: 28878676 Free PMC article. Highly Cited. Review.
|
PD-L1. Anthousa Kythreotou, Abdul Siddique, +2 authors, Francesco A Mauri, Mark Bower, David J Pinato. less J Clin Pathol, 2017 Nov 04; 71(3). PMID: 29097600 Highly Cited. Review.
|
The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma. Satu Salmi, Hanna Siiskonen, +5 authors, Reijo Sironen, Kristiina Tyynelä-Korhonen, Benjamin Hirschovits-Gerz, Mari Valkonen, Päivi Auvinen, Sanna Pasonen-Seppänen. less Melanoma Res, 2018 Nov 07; 29(3). PMID: 30399061 Free PMC article.
|
Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma. Fei Zhao, Kathy Evans, +6 authors, Christine Xiao, Nicholas DeVito, Balamayooran Theivanthiran, Alisha Holtzhausen, Peter J Siska, Gerard C Blobe, Brent A Hanks. less Cancer Immunol Res, 2018 Sep 14; 6(12). PMID: 30209062 Free PMC article.
|
Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Daniel G Coit, John A Thompson, +27 authors, Mark R Albertini, Christopher Barker, William E Carson, Carlo Contreras, Gregory A Daniels, Dominick DiMaio, Ryan C Fields, Martin D Fleming, Morganna Freeman, Anjela Galan, Brian Gastman, Valerie Guild, Douglas Johnson, Richard W Joseph, Julie R Lange, Sameer Nath, Anthony J Olszanski, Patrick Ott, Aparna Priyanath Gupta, Merrick I Ross, April K Salama, Joseph Skitzki, Jeffrey Sosman, Susan M Swetter, Kenneth K Tanabe, Evan Wuthrick, Nicole R McMillian, Anita M Engh. less J Natl Compr Canc Netw, 2019 Apr 09; 17(4). PMID: 30959471 Highly Cited.
|
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. Julien Fourcade, Zhaojun Sun, +6 authors, Mourad Benallaoua, Philippe Guillaume, Immanuel F Luescher, Cindy Sander, John M Kirkwood, Vijay Kuchroo, Hassane M Zarour. less J Exp Med, 2010 Sep 08; 207(10). PMID: 20819923 Free PMC article. Highly Cited.
|
Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression. Anders Etzerodt, Kyriaki Tsalkitzi, +9 authors, Maciej Maniecki, William Damsky, Marcello Delfini, Elodie Baudoin, Morgane Moulin, Marcus Bosenberg, Jonas Heilskov Graversen, Nathalie Auphan-Anezin, Søren Kragh Moestrup, Toby Lawrence. less J Exp Med, 2019 Aug 04; 216(10). PMID: 31375534 Free PMC article. Highly Cited.
|
Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and Beyond. Kristina Buder-Bakhaya, Jessica C Hassel. Front Immunol, 2018 Jul 14; 9. PMID: 30002656 Free PMC article. Highly Cited. Review.
|
Pro-tumor activities of macrophages in the progression of melanoma. Huafeng Wang, Luhong Yang, +2 authors, Dong Wang, Qi Zhang, Lijuan Zhang. less Hum Vaccin Immunother, 2017 Apr 26; 13(7). PMID: 28441072 Free PMC article. Review.
|
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. James Larkin, Vanna Chiarion-Sileni, +28 authors, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier F Ferrucci, Michael Smylie, David Hogg, Andrew Hill, Ivan Márquez-Rodas, John Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S Carlino, Céleste Lebbé, Grant McArthur, Paolo A Ascierto, Gregory A Daniels, Georgina V Long, Lars Bastholt, Jasmine I Rizzo, Agnes Balogh, Andriy Moshyk, F Stephen Hodi, Jedd D Wolchok. less N Engl J Med, 2019 Sep 29; 381(16). PMID: 31562797 Highly Cited.
|
Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution. Line Pedersen, Manja Idorn, +12 authors, Gitte H Olofsson, Britt Lauenborg, Intawat Nookaew, Rasmus Hvass Hansen, Helle Hjorth Johannesen, Jürgen C Becker, Katrine S Pedersen, Christine Dethlefsen, Jens Nielsen, Julie Gehl, Bente K Pedersen, Per Thor Straten, Pernille Hojman. less Cell Metab, 2016 Feb 21; 23(3). PMID: 26895752 Highly Cited.
|
Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma. Hector Terán-Navarro, Ricardo Calderon-Gonzalez, +13 authors, David Salcines-Cuevas, Isabel García, Marco Marradi, Javier Freire, Erwan Salmon, Mar Portillo-Gonzalez, Elisabet Frande-Cabanes, Almudena García-Castaño, Virginia Martinez-Callejo, Javier Gomez-Roman, Raquel Tobes, Fernando Rivera, Sonsoles Yañez-Diaz, Carmen Álvarez-Domínguez. less Oncoimmunology, 2019 Feb 05; 8(2). PMID: 30713801 Free PMC article.
|
Regulatory T-cell heterogeneity and the cancer immune response. Kirsten A Ward-Hartstonge, Roslyn A Kemp. Clin Transl Immunology, 2017 Oct 07; 6(9). PMID: 28983402 Free PMC article. Review.
|
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC. Marzia Del Re, Riccardo Marconcini, +12 authors, Giulia Pasquini, Eleonora Rofi, Caterina Vivaldi, Francesco Bloise, Giuliana Restante, Elena Arrigoni, Chiara Caparello, Maria Grazia Bianco, Stefania Crucitta, Iacopo Petrini, Enrico Vasile, Alfredo Falcone, Romano Danesi. less Br J Cancer, 2018 Mar 07; 118(6). PMID: 29509748 Free PMC article. Highly Cited.
|
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. Lillian Sun, Paul E Clavijo, +12 authors, Yvette Robbins, Priya Patel, Jay Friedman, Sarah Greene, Rita Das, Chris Silvin, Carter Van Waes, Lucas A Horn, Jeffrey Schlom, Claudia Palena, Dean Maeda, John Zebala, Clint T Allen. less JCI Insight, 2019 Apr 05; 4(7). PMID: 30944253 Free PMC article. Highly Cited.
|
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy. Melvyn T Chow, Aleksandra J Ozga, +6 authors, Rachel L Servis, Dennie T Frederick, Jennifer A Lo, David E Fisher, Gordon J Freeman, Genevieve M Boland, Andrew D Luster. less Immunity, 2019 May 18; 50(6). PMID: 31097342 Free PMC article. Highly Cited.
|
Entinostat Helps Thwart Immunotherapy Resistance. Cancer Discov, 2019 Apr 03; 9(6). PMID: 30936082
|
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Vyara Matson, Jessica Fessler, +5 authors, Riyue Bao, Tara Chongsuwat, Yuanyuan Zha, Maria-Luisa Alegre, Jason J Luke, Thomas F Gajewski. less Science, 2018 Jan 06; 359(6371). PMID: 29302014 Free PMC article. Highly Cited.
|
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance. Vivek Verma, Rajeev K Shrimali, +25 authors, Shamim Ahmad, Winjie Dai, Hua Wang, Sumin Lu, Rahul Nandre, Pankaj Gaur, Jose Lopez, Moshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, Keith T Flaherty, Jennifer A Wargo, Genevieve M Boland, Ryan J Sullivan, Gad Getz, Scott A Hammond, Ming Tan, Jingjing Qi, Phillip Wong, Taha Merghoub, Jedd Wolchok, Nir Hacohen, John E Janik, Mikayel Mkrtichyan, Seema Gupta, Samir N Khleif. less Nat Immunol, 2019 Jul 31; 20(9). PMID: 31358999 Free PMC article. Highly Cited.
|
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia. Nicole E Scharping, Ashley V Menk, +2 authors, Ryan D Whetstone, Xue Zeng, Greg M Delgoffe. less Cancer Immunol Res, 2016 Dec 13; 5(1). PMID: 27941003 Free PMC article. Highly Cited.
|
Stromal Cells in the Tumor Microenvironment. Alice E Denton, Edward W Roberts, Douglas T Fearon. Adv Exp Med Biol, 2018 Aug 30; 1060. PMID: 30155624 Review.
|
Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells. Theodore Kouo, Lanqing Huang, +4 authors, Alexandra B Pucsek, Minwei Cao, Sara Solt, Todd Armstrong, Elizabeth Jaffee. less Cancer Immunol Res, 2015 Feb 19; 3(4). PMID: 25691328 Free PMC article. Highly Cited.
|
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors. Jeffrey M Conroy, Sarabjot Pabla, +37 authors, Mary K Nesline, Sean T Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Jonathan Andreas, Vincent Giamo, Yirong Wang, Felicia L Lenzo, Wiam Bshara, Maya Khalil, Grace K Dy, Katherine G Madden, Keisuke Shirai, Konstantin Dragnev, Laura J Tafe, Jason Zhu, Matthew Labriola, Daniele Marin, Shannon J McCall, Jeffrey Clarke, Daniel J George, Tian Zhang, Matthew Zibelman, Pooja Ghatalia, Isabel Araujo-Fernandez, Luis de la Cruz-Merino, Arun Singavi, Ben George, Alexander C MacKinnon, Jonathan Thompson, Rajbir Singh, Robin Jacob, Deepa Kasuganti, Neel Shah, Roger Day, Lorenzo Galluzzi, Mark Gardner, Carl Morrison. less J Immunother Cancer, 2019 Jan 27; 7(1). PMID: 30678715 Free PMC article.
|
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Jedd D Wolchok, Axel Hoos, +9 authors, Steven O'Day, Jeffrey S Weber, Omid Hamid, Celeste Lebbé, Michele Maio, Michael Binder, Oliver Bohnsack, Geoffrey Nichol, Rachel Humphrey, F Stephen Hodi. less Clin Cancer Res, 2009 Nov 26; 15(23). PMID: 19934295 Highly Cited.
|
Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients. Huanhuan Jiang, Christoffer Gebhardt, +4 authors, Ludmila Umansky, Philipp Beckhove, Torsten J Schulze, Jochen Utikal, Viktor Umansky. less Int J Cancer, 2014 Oct 30; 136(10). PMID: 25353097
|
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Noweeda Mirza, Mayer Fishman, +6 authors, Ingo Fricke, Mary Dunn, Anthony M Neuger, Timothy J Frost, Richard M Lush, Scott Antonia, Dmitry I Gabrilovich. less Cancer Res, 2006 Sep 20; 66(18). PMID: 16982775 Free PMC article. Highly Cited.
|
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. V Gopalakrishnan, C N Spencer, +67 authors, L Nezi, A Reuben, M C Andrews, T V Karpinets, P A Prieto, D Vicente, K Hoffman, S C Wei, A P Cogdill, L Zhao, C W Hudgens, D S Hutchinson, T Manzo, M Petaccia de Macedo, T Cotechini, T Kumar, W S Chen, S M Reddy, R Szczepaniak Sloane, J Galloway-Pena, H Jiang, P L Chen, E J Shpall, K Rezvani, A M Alousi, R F Chemaly, S Shelburne, L M Vence, P C Okhuysen, V B Jensen, A G Swennes, F McAllister, E Marcelo Riquelme Sanchez, Y Zhang, E Le Chatelier, L Zitvogel, N Pons, J L Austin-Breneman, L E Haydu, E M Burton, J M Gardner, E Sirmans, J Hu, A J Lazar, T Tsujikawa, A Diab, H Tawbi, I C Glitza, W J Hwu, S P Patel, S E Woodman, R N Amaria, M A Davies, J E Gershenwald, P Hwu, J E Lee, J Zhang, L M Coussens, Z A Cooper, P A Futreal, C R Daniel, N J Ajami, J F Petrosino, M T Tetzlaff, P Sharma, J P Allison, R R Jenq, J A Wargo. less Science, 2017 Nov 04; 359(6371). PMID: 29097493 Free PMC article. Highly Cited.
|
TIGIT predominantly regulates the immune response via regulatory T cells. Sema Kurtulus, Kaori Sakuishi, +6 authors, Shin-Foong Ngiow, Nicole Joller, Dewar J Tan, Michele W L Teng, Mark J Smyth, Vijay K Kuchroo, Ana C Anderson. less J Clin Invest, 2015 Sep 29; 125(11). PMID: 26413872 Free PMC article. Highly Cited.
|
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab. Christoffer Gebhardt, Alexandra Sevko, +10 authors, Huanhuan Jiang, Ramtin Lichtenberger, Maike Reith, Kathrin Tarnanidis, Tim Holland-Letz, Ludmila Umansky, Philipp Beckhove, Antje Sucker, Dirk Schadendorf, Jochen Utikal, Viktor Umansky. less Clin Cancer Res, 2015 Aug 21; 21(24). PMID: 26289067 Highly Cited.
|
Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Matthew Kraman, Paul J Bambrough, +6 authors, James N Arnold, Edward W Roberts, Lukasz Magiera, James O Jones, Aarthi Gopinathan, David A Tuveson, Douglas T Fearon. less Science, 2010 Nov 06; 330(6005). PMID: 21051638 Highly Cited.
|
High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma. J Zaragoza, A Caille, +4 authors, N Beneton, G Bens, F Christiann, H Maillard, L Machet. less Br J Dermatol, 2015 Sep 08; 174(1). PMID: 26343230
|
The biology and function of fibroblasts in cancer. Raghu Kalluri. Nat Rev Cancer, 2016 Aug 24; 16(9). PMID: 27550820 Highly Cited. Review.
|
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Rodabe N Amaria, Sangeetha M Reddy, +42 authors, Hussein A Tawbi, Michael A Davies, Merrick I Ross, Isabella C Glitza, Janice N Cormier, Carol Lewis, Wen-Jen Hwu, Ehab Hanna, Adi Diab, Michael K Wong, Richard Royal, Neil Gross, Randal Weber, Stephen Y Lai, Richard Ehlers, Jorge Blando, Denái R Milton, Scott Woodman, Robin Kageyama, Daniel K Wells, Patrick Hwu, Sapna P Patel, Anthony Lucci, Amy Hessel, Jeffrey E Lee, Jeffrey Gershenwald, Lauren Simpson, Elizabeth M Burton, Liberty Posada, Lauren Haydu, Linghua Wang, Shaojun Zhang, Alexander J Lazar, Courtney W Hudgens, Vancheswaran Gopalakrishnan, Alexandre Reuben, Miles C Andrews, Christine N Spencer, Victor Prieto, Padmanee Sharma, James Allison, Michael T Tetzlaff, Jennifer A Wargo. less Nat Med, 2018 Oct 10; 24(11). PMID: 30297909 Free PMC article. Highly Cited.
|
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lesley Seymour, Jan Bogaerts, +16 authors, Andrea Perrone, Robert Ford, Lawrence H Schwartz, Sumithra Mandrekar, Nancy U Lin, Saskia Litière, Janet Dancey, Alice Chen, F Stephen Hodi, Patrick Therasse, Otto S Hoekstra, Lalitha K Shankar, Jedd D Wolchok, Marcus Ballinger, Caroline Caramella, Elisabeth G E de Vries, RECIST working group. less Lancet Oncol, 2017 Mar 09; 18(3). PMID: 28271869 Free PMC article. Highly Cited. Review.
|
The immune contexture in human tumours: impact on clinical outcome. Wolf Herman Fridman, Franck Pagès, Catherine Sautès-Fridman, Jérôme Galon. Nat Rev Cancer, 2012 Mar 16; 12(4). PMID: 22419253 Highly Cited. Review.
|
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. Christopher Groth, Xiaoying Hu, +4 authors, Rebekka Weber, Viktor Fleming, Peter Altevogt, Jochen Utikal, Viktor Umansky. less Br J Cancer, 2018 Nov 11; 120(1). PMID: 30413826 Free PMC article. Highly Cited. Review.
|
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe). Jessica C Hassel, Huanhuan Jiang, +10 authors, Carolin Bender, Julia Winkler, Alexandra Sevko, Ivan Shevchenko, Niels Halama, Antonia Dimitrakopoulou-Strauss, Walter E Haefeli, Dirk Jäger, Alexander Enk, Jochen Utikal, Viktor Umansky. less Oncoimmunology, 2017 Sep 22; 6(9). PMID: 28932631 Free PMC article.
|
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma. Scott J Rodig, Daniel Gusenleitner, +13 authors, Donald G Jackson, Evisa Gjini, Anita Giobbie-Hurder, Chelsea Jin, Han Chang, Scott B Lovitch, Christine Horak, Jeffrey S Weber, Jason L Weirather, Jedd D Wolchok, Michael A Postow, Anna C Pavlick, Jason Chesney, F Stephen Hodi. less Sci Transl Med, 2018 Jul 20; 10(450). PMID: 30021886 Highly Cited.
|
Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma. Robyn D Gartrell-Corrado, Andrew X Chen, +14 authors, Emanuelle M Rizk, Douglas K Marks, Margaret H Bogardus, Thomas D Hart, Andrew M Silverman, Claire-Audrey Y Bayan, Grace G Finkel, Luke W Barker, Kimberly M Komatsubara, Richard D Carvajal, Basil A Horst, Rui Chang, Anthea Monod, Raul Rabadan, Yvonne M Saenger. less Cancer Res, 2020 Jan 18; 80(5). PMID: 31948941 Free PMC article.
|
The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy. Long Long, Xue Zhang, +4 authors, Fuchun Chen, Qi Pan, Pronnaphat Phiphatwatchara, Yuyang Zeng, Honglei Chen. less Genes Cancer, 2019 Jan 04; 9(5-6). PMID: 30603054 Free PMC article. Highly Cited. Review.
|
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma. Nanumi Han, Muhammad Baghdadi, +6 authors, Kozo Ishikawa, Hiraku Endo, Takuto Kobayashi, Haruka Wada, Keisuke Imafuku, Hiroo Hata, Ken-Ichiro Seino. less Inflamm Regen, 2018 Mar 09; 38. PMID: 29515691 Free PMC article.
|
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. Antoni Ribas, Reinhard Dummer, +17 authors, Igor Puzanov, Ari VanderWalde, Robert H I Andtbacka, Olivier Michielin, Anthony J Olszanski, Josep Malvehy, Jonathan Cebon, Eugenio Fernandez, John M Kirkwood, Thomas F Gajewski, Lisa Chen, Kevin S Gorski, Abraham A Anderson, Scott J Diede, Michael E Lassman, Jennifer Gansert, F Stephen Hodi, Georgina V Long. less Cell, 2017 Sep 09; 170(6). PMID: 28886381 Free PMC article. Highly Cited.
|
Tumor infiltrating lymphocytes: The regulator of melanoma evolution. Mihaela Antohe, Roxana Ioana Nedelcu, +12 authors, Luciana Nichita, Cristiana Gabriela Popp, Mirela Cioplea, Alice Brinzea, Anastasia Hodorogea, Andreea Calinescu, Mihaela Balaban, Daniela Adriana Ion, Carmen Diaconu, Coralia Bleotu, Daniel Pirici, Sabina Andrada Zurac, Gabriela Turcu. less Oncol Lett, 2019 Apr 05; 17(5). PMID: 30944610 Free PMC article. Review.
|
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation. Ana C Anderson, Nicole Joller, Vijay K Kuchroo. Immunity, 2016 May 19; 44(5). PMID: 27192565 Free PMC article. Highly Cited. Review.
|
A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression. Kathleen M Mahoney, Sachet A Shukla, +14 authors, Nikolaos Patsoukis, Apoorvi Chaudhri, Edward P Browne, Arnon Arazi, Thomas M Eisenhaure, William F Pendergraft, Ping Hua, Hung C Pham, Xia Bu, Baogong Zhu, Nir Hacohen, Edward F Fritsch, Vassiliki A Boussiotis, Catherine J Wu, Gordon J Freeman. less Cancer Immunol Immunother, 2018 Dec 20; 68(3). PMID: 30564891 Free PMC article.
|
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers. Anu Sharma, Sumit K Subudhi, +6 authors, Jorge Blando, Jorge Scutti, Luis Vence, Jennifer Wargo, James P Allison, Antoni Ribas, Padmanee Sharma. less Clin Cancer Res, 2018 Jul 29; 25(4). PMID: 30054281 Free PMC article. Highly Cited.
|
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. Tyler R Simpson, Fubin Li, +11 authors, Welby Montalvo-Ortiz, Manuel A Sepulveda, Katharina Bergerhoff, Frederick Arce, Claire Roddie, Jake Y Henry, Hideo Yagita, Jedd D Wolchok, Karl S Peggs, Jeffrey V Ravetch, James P Allison, Sergio A Quezada. less J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981 Free PMC article. Highly Cited.
|
FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma. A C Tan, L Emmett, +6 authors, S Lo, V Liu, R Kapoor, M S Carlino, A D Guminski, G V Long, A M Menzies. less Ann Oncol, 2018 Aug 24; 29(10). PMID: 30137228
|
Myeloid-derived suppressor cells coming of age. Filippo Veglia, Michela Perego, Dmitry Gabrilovich. Nat Immunol, 2018 Jan 20; 19(2). PMID: 29348500 Free PMC article. Highly Cited. Review.
|
Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells. Joel Baumgartner, Cara Wilson, +3 authors, Brent Palmer, Don Richter, Anirban Banerjee, Martin McCarter. less J Surg Res, 2007 Jun 19; 141(1). PMID: 17574040 Free PMC article.
|
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Vincenzo Bronte, Sven Brandau, +12 authors, Shu-Hsia Chen, Mario P Colombo, Alan B Frey, Tim F Greten, Susanna Mandruzzato, Peter J Murray, Augusto Ochoa, Suzanne Ostrand-Rosenberg, Paulo C Rodriguez, Antonio Sica, Viktor Umansky, Robert H Vonderheide, Dmitry I Gabrilovich. less Nat Commun, 2016 Jul 07; 7. PMID: 27381735 Free PMC article. Highly Cited. Review.
|
The concept of immune surveillance against tumors. The first theories. Domenico Ribatti. Oncotarget, 2016 Oct 21; 8(4). PMID: 27764780 Free PMC article. Highly Cited. Review.
|
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody. Danbee Ha, Atsushi Tanaka, +10 authors, Tatsuya Kibayashi, Atsushi Tanemura, Daisuke Sugiyama, James Badger Wing, Ee Lyn Lim, Karen Wei Weng Teng, Dennis Adeegbe, Evan W Newell, Ichiro Katayama, Hiroyoshi Nishikawa, Shimon Sakaguchi. less Proc Natl Acad Sci U S A, 2018 Dec 28; 116(2). PMID: 30587582 Free PMC article.
|
Fibroblast-mediated drug resistance in cancer. Kim H T Paraiso, Keiran S M Smalley. Biochem Pharmacol, 2013 Feb 05; 85(8). PMID: 23376122 Review.
|
Pembrolizumab versus Ipilimumab in Advanced Melanoma. Caroline Robert, Jacob Schachter, +20 authors, Georgina V Long, Ana Arance, Jean Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona McNeil, Michal Lotem, James Larkin, Paul Lorigan, Bart Neyns, Christian U Blank, Omid Hamid, Christine Mateus, Ronnie Shapira-Frommer, Michele Kosh, Honghong Zhou, Nageatte Ibrahim, Scot Ebbinghaus, Antoni Ribas, KEYNOTE-006 investigators. less N Engl J Med, 2015 Apr 22; 372(26). PMID: 25891173 Highly Cited.
|
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point 18F-FDG PET/CT Imaging in Patients with Advanced Melanoma. Steve Y Cho, Evan J Lipson, +7 authors, Hyung-Jun Im, Steven P Rowe, Esther Mena Gonzalez, Amanda Blackford, Alin Chirindel, Drew M Pardoll, Suzanne L Topalian, Richard L Wahl. less J Nucl Med, 2017 Apr 01; 58(9). PMID: 28360208 Free PMC article. Highly Cited.
|
Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy. Shan Gao, Dongjuan Yang, +6 authors, Yan Fang, Xiaojie Lin, Xuechao Jin, Qi Wang, Xiyan Wang, Liyuan Ke, Kai Shi. less Theranostics, 2019 Jan 22; 9(1). PMID: 30662558 Free PMC article. Highly Cited. Review.
|
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Laurent Monney, Catherine A Sabatos, +9 authors, Jason L Gaglia, Akemi Ryu, Hanspeter Waldner, Tatyana Chernova, Stephen Manning, Edward A Greenfield, Anthony J Coyle, Raymond A Sobel, Gordon J Freeman, Vijay K Kuchroo. less Nature, 2002 Feb 02; 415(6871). PMID: 11823861 Highly Cited.
|
Mechanisms of checkpoint inhibition-induced adverse events. P Urwyler, I Earnshaw, +9 authors, M Bermudez, E Perucha, W Wu, S Ryan, L Mcdonald, S N Karagiannis, L S Taams, N Powell, A Cope, S Papa. less Clin Exp Immunol, 2020 Jan 29; 200(2). PMID: 31989585 Free PMC article. Review.
|
The role of tumor microenvironment in melanoma therapy resistance. Rajasekharan Somasundaram, Meenhard Herlyn, Stephan N Wagner. Melanoma Manag, 2016 Mar 01; 3(1). PMID: 30190870 Free PMC article. Review.
|
Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma. Naoya Yamazaki, Yoshio Kiyohara, +11 authors, Hisashi Uhara, Hajime Iizuka, Jiro Uehara, Fujio Otsuka, Yasuhiro Fujisawa, Tatsuya Takenouchi, Taiki Isei, Keiji Iwatsuki, Hiroshi Uchi, Hironobu Ihn, Hironobu Minami, Hideaki Tahara. less Cancer Sci, 2017 Mar 08; 108(5). PMID: 28266140 Free PMC article.
|
Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies. Spencer C Wei, Nana-Ama A S Anang, +8 authors, Roshan Sharma, Miles C Andrews, Alexandre Reuben, Jacob H Levine, Alexandria P Cogdill, James J Mancuso, Jennifer A Wargo, Dana Pe'er, James P Allison. less Proc Natl Acad Sci U S A, 2019 Oct 23; 116(45). PMID: 31636208 Free PMC article.
|
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab. Richard P Tobin, Kimberly R Jordan, +5 authors, William A Robinson, Dana Davis, Virginia F Borges, Rene Gonzalez, Karl D Lewis, Martin D McCarter. less Int Immunopharmacol, 2018 Aug 20; 63. PMID: 30121453 Free PMC article.
|
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial. Frank Stephen Hodi, Vanna Chiarion-Sileni, +16 authors, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Charles Lance Cowey, Christopher D Lao, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, Andrew Hill, David Hogg, Ivan Marquez-Rodas, Joel Jiang, Jasmine Rizzo, James Larkin, Jedd D Wolchok. less Lancet Oncol, 2018 Oct 27; 19(11). PMID: 30361170 Highly Cited.
|
Melanoma antigens and related immunological markers. Jacob Pitcovski, Ehud Shahar, Elina Aizenshtein, Raphael Gorodetsky. Crit Rev Oncol Hematol, 2017 Jun 13; 115. PMID: 28602168 Review.
|
Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer. Chiao-Wen Kang, Avijit Dutta, +8 authors, Li-Yuan Chang, Jayashri Mahalingam, Yung-Chang Lin, Jy-Ming Chiang, Chen-Yu Hsu, Ching-Tai Huang, Wan-Ting Su, Yu-Yi Chu, Chun-Yen Lin. less Sci Rep, 2015 Oct 27; 5. PMID: 26493689 Free PMC article.
|
Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients. Ryan J Sullivan, Omid Hamid, +13 authors, Rene Gonzalez, Jeffrey R Infante, Manish R Patel, F Stephen Hodi, Karl D Lewis, Hussein A Tawbi, Genevive Hernandez, Matthew J Wongchenko, YiMeng Chang, Louise Roberts, Marcus Ballinger, Yibing Yan, Edward Cha, Patrick Hwu. less Nat Med, 2019 Jun 07; 25(6). PMID: 31171876 Highly Cited.
|
Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells. Katrin Moses, Sven Brandau. Semin Immunol, 2016 Apr 14; 28(2). PMID: 27067179 Highly Cited. Review.
|
Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma. Pok Fai Wong, Wei Wei, +4 authors, Swati Gupta, James W Smithy, Daniel Zelterman, Harriet M Kluger, David L Rimm. less J Immunother Cancer, 2019 Jul 25; 7(1). PMID: 31337426 Free PMC article.
|
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. O Hamid, C Robert, +17 authors, A Daud, F S Hodi, W J Hwu, R Kefford, J D Wolchok, P Hersey, R Joseph, J S Weber, R Dronca, T C Mitchell, A Patnaik, H M Zarour, A M Joshua, Q Zhao, E Jensen, S Ahsan, N Ibrahim, A Ribas. less Ann Oncol, 2019 Feb 05; 30(4). PMID: 30715153 Free PMC article. Highly Cited.
|
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory. Mauro Poggio, Tianyi Hu, +8 authors, Chien-Chun Pai, Brandon Chu, Cassandra D Belair, Anthony Chang, Elizabeth Montabana, Ursula E Lang, Qi Fu, Lawrence Fong, Robert Blelloch. less Cell, 2019 Apr 06; 177(2). PMID: 30951669 Free PMC article. Highly Cited.
|
Basis of PD1/PD-L1 Therapies. Barbara Seliger. J Clin Med, 2019 Dec 11; 8(12). PMID: 31817953 Free PMC article. Review.
|
Neutrophils in cancer: neutral no more. Seth B Coffelt, Max D Wellenstein, Karin E de Visser. Nat Rev Cancer, 2016 Jun 11; 16(7). PMID: 27282249 Highly Cited. Review.
|
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors. Salah-Eddine Bentebibel, Michael E Hurwitz, +14 authors, Chantale Bernatchez, Cara Haymaker, Courtney W Hudgens, Harriet M Kluger, Michael T Tetzlaff, Mary A Tagliaferri, Jonathan Zalevsky, Ute Hoch, Christie Fanton, Sandra Aung, Patrick Hwu, Brendan D Curti, Nizar M Tannir, Mario Sznol, Adi Diab. less Cancer Discov, 2019 Apr 17; 9(6). PMID: 30988166 Highly Cited.
|